Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in CYTOKINETICS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 235,049 shares of CYTK (CYTOKINETICS INC), worth $14.9M as of 2025-Q4. The position was decreased (-1.4% shares). CYTK represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$14.9M
Current Shares
235,049
Total Value Change
+$1.3M
Total Shares Change
-16,893
Other major holders of CYTK: BNP PARIBAS FINANCIAL MARKETS
Decreased |
| 235,049 |
-1.4% |
| $14.9M |
| 0.0% |
| $61.37 |
0 |
| 2025-Q3 | Decreased | 238,382 | -42.7% | $13.1M | 0.0% | $53.89 | 0 |
| 2025-Q2 | Increased | 416,253 | +34.8% | $13.8M | 0.0% | $33.16 | 36 |
| 2025-Q1 | Decreased | 308,896 | -2.0% | $12.4M | 0.0% | $43.19 | 0 |
| 2024-Q4 | Increased | 315,250 | +18.2% | $14.8M | 0.0% | $47.15 | 33 |
| 2024-Q3 | Increased | 266,756 | +5.9% | $14.1M | 0.0% | $52.34 | 30 |
| 2024-Q2 | Increased | 251,942 | +113.7% | $13.7M | 0.0% | $54.18 | 45 |